| scholarly article | Q13442814 |
| P2093 | author name string | Susana Mendez | |
| Wenhui Wu | |||
| Eva Maria Laabs | |||
| P2860 | cites work | Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis | Q27318814 |
| Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides | Q28510289 | ||
| Interleukin-12 and the regulation of innate resistance and adaptive immunity | Q29614602 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Leishmaniasis: current situation and new perspectives | Q34330071 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| The immunology of susceptibility and resistance to Leishmania major in mice | Q34988360 | ||
| Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias | Q35216156 | ||
| Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability | Q35802037 | ||
| CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells | Q35971414 | ||
| Helper role of NK cells during the induction of anticancer responses by dendritic cells | Q35988425 | ||
| Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice | Q36362141 | ||
| A contribution of mouse dendritic cell-derived IL-2 for NK cell activation | Q36399726 | ||
| Regulatory T-cell compartmentalization and trafficking | Q36421407 | ||
| Modulation of NK cell activity by CpG oligodeoxynucleotides | Q36961016 | ||
| The role of the innate immune response in Th1 cell development following Leishmania major infection. | Q40509369 | ||
| Reciprocal activating interaction between natural killer cells and dendritic cells | Q41992239 | ||
| Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells | Q42005335 | ||
| TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. | Q46561897 | ||
| Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. | Q47644110 | ||
| Early parasite containment is decisive for resistance to Leishmania major infection. | Q54166265 | ||
| Treatment of recurrent cutaneous Leishmaniasis. | Q54181533 | ||
| Cutaneous leishmaniasis: an increasing threat for travellers. | Q54671661 | ||
| Control of Leishmania major in the absence of Tyk2 kinase. | Q54730490 | ||
| A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation | Q77365877 | ||
| Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection | Q77823585 | ||
| The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells | Q78842088 | ||
| Natural killer (NK) cell functions can be strongly boosted by activated dendritic cells (DC) | Q79169943 | ||
| NKT cells mediate organ-specific resistance against Leishmania major infection | Q81379952 | ||
| Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12 | Q81434882 | ||
| P433 | issue | 11 | |
| P921 | main subject | interleukins | Q194908 |
| Leishmania major | Q1950715 | ||
| dermal dendritic cell | Q113044521 | ||
| P304 | page(s) | 1601-1606 | |
| P577 | publication date | 2009-09-23 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation | |
| P478 | volume | 16 |
| Q42670769 | A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice. |
| Q38008347 | Activation of natural killer cells during microbial infections |
| Q36021357 | Adjuvants for Leishmania vaccines: from models to clinical application |
| Q35102709 | CD4 T cell activation by B cells in human Leishmania (Viannia) infection |
| Q35571431 | Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice. |
| Q88510856 | Cutaneous Leishmaniasis: Update on Vaccine Development |
| Q38855600 | Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in mice. |
| Q37811555 | Innate Immunity and Leishmania Vaccination Strategies |
| Q82941724 | Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis |
| Q38037557 | Natural killer cells in experimental and human leishmaniasis |
| Q38015852 | Protective immunity and vaccination against cutaneous leishmaniasis. |
| Q38011653 | Therapeutic live vaccines as a potential anticancer strategy. |
| Q39180425 | Trichinella spiralis infection reduces tumor growth and metastasis of B16-F10 melanoma cells |
Search more.